O
Ole Wichmann
Researcher at Robert Koch Institute
Publications - 228
Citations - 7533
Ole Wichmann is an academic researcher from Robert Koch Institute. The author has contributed to research in topics: Vaccination & Population. The author has an hindex of 43, co-authored 200 publications receiving 6223 citations. Previous affiliations of Ole Wichmann include Ludwig Maximilian University of Munich & Humboldt University of Berlin.
Papers
More filters
Group report: assessing the feasibility of an eradication initiative
Steven Cochi,Walter R. Dowdle,Peter Strebel,Eric Ottesen,Ciro de Quadros,S Guirguis,Robert Hall,Linda Muller,Jai P Narain,Ole Wichmann +9 more
TL;DR: This chapter builds on earlier work that describes the biological and technical requirements for disease eradication and focuses in more detail on nonbiological, critical enabling factors and plays a cross-cutting role in building and sustaining the necessary political and societal support for eradication.
Journal ArticleDOI
Seroprevalence of mucosal and cutaneous human papillomavirus (HPV) types among children and adolescents in the general population in Germany
Anna D. Loenenbach,Michael Pawlita,Tim Waterboer,Thomas Harder,Christina Poethko-Müller,Michael Thamm,Raskit Lachmann,Yvonne Deleré,Ole Wichmann,Miriam Wiese-Posselt +9 more
TL;DR: In this article , the prevalence and determinants of serological response to 16 different HPV types in a representative sample of 12,257 boys and girls aged 1-17 years living in Germany in 2003-2005.
Journal ArticleDOI
Impfprävention in Deutschland: Ein Überblick zu den Entwicklungen der letzten 25 Jahren
TL;DR: Die Empfehlungen der Ständigen Impfkommission (STIKO) tragen zu einem effektiven Schutz vor übertragbaren Erkrankungen in der Allgemeinbevölkerung and auch in speziellen Risikogruppen bei.
Posted ContentDOI
Estimating the distribution of COVID-19-susceptible, -recovered, and -vaccinated individuals in Germany up to April 2022
Benjamin F. Maier,Annika H. Rose,Angelique Burdinski,Pascal Klamser,H. Neuhauser,Ole Wichmann,Lars Schaade,Lothar H. Wieler,Dirk Brockmann +8 more
TL;DR: A high share of individuals with SARS-CoV-2 immunity lowers the probability of severe outbreaks that could potentially overburden the public health system once again, given that emerging variants do not escape this reduction in susceptibility.
Journal ArticleDOI
Die neue Standardvorgehensweise der Ständigen Impfkommission (STIKO): Entstehung, Struktur und Umsetzung
TL;DR: In Deutschland, standige Impfkommission (STIKO) empfehlungen zur Durchfuhrung von Schutzimpfungen and zur durchfahrung anderer Masnahmen der spezifischen Prophylaxe ubertragbarer Krankheiten werden verabschiedet as mentioned in this paper.